How Sympathetic Nerve Firing Patterns Control Neuropeptide Y Levels in Humans | Research

The takeaway

This first-in-human study demonstrated that sympathetic nerve firing frequency and recruitment patterns directly regulate neuropeptide Y (NPY) bioavailability, revealing a key mechanism for how the nervous system controls blood vessel function.

First human evidence of NPY regulation by nerve firing patterns
Sympathetic AP frequency and cluster recruitment were significantly associated with neuropeptide Y blood levels (P = 0.003 and P = 0.005)

What the researchers found

NPY levels were positively associated with mean arterial pressure (β = 1.63, P = 0.002), total action potential clusters (β = 0.90, P = 0.005), and action potential frequency (β = 0.11, P = 0.003). This shows that both the rate of nerve firing and the pattern of nerve fiber recruitment regulate NPY release.

Norepinephrine levels were also positively related to AP clusters (β = 19.50, P = 0.030) and AP frequency (β = 2.66, P = 0.014) but notably were not significantly related to mean arterial pressure (P = 0.133). This distinction suggests that NPY, rather than norepinephrine alone, may be the neurotransmitter more closely linked to blood pressure regulation through sympathetic nerve activity patterns.

Why it matters

Neuropeptide Y is one of the most abundant peptides in the nervous system and plays critical roles in blood pressure regulation, appetite, anxiety, and immune function. Understanding exactly how the nervous system controls NPY release has been a fundamental gap in neuroscience. This study provides the first human evidence that specific nerve firing strategies — not just overall nerve activity — determine NPY availability, opening new avenues for understanding cardiovascular regulation and potentially treating conditions like hypertension.

How the study worked

Six healthy individuals (5 females, mean age 27 years) underwent microneurography — a technique where a fine electrode is inserted into a peripheral nerve to record individual sympathetic nerve fiber activity. A continuous wavelet transform was used to detect individual sympathetic action potentials. Measurements were taken at baseline and during intravenous dexmedetomidine infusion (an α2-adrenergic agonist that modulates sympathetic activity). Arterial blood samples provided NPY and norepinephrine levels. Linear mixed-model regressions assessed relationships between nerve firing patterns and neurotransmitter levels.

What this study cannot tell us

Very small sample size (n=6) limits statistical power and generalizability. The study was conducted in young, healthy individuals and may not reflect patterns in older adults or those with cardiovascular disease. Dexmedetomidine has multiple physiological effects beyond sympathetic modulation that could confound results. Microneurography measures a specific nerve bed and may not represent sympathetic activity to all vascular territories.

How to read the evidence

This is a novel mechanistic study in humans using sophisticated neurophysiology techniques. While the experimental design is rigorous and the findings are novel, the very small sample size (n=6) means these results should be considered preliminary and in need of replication in larger cohorts.

When this study was published

Published in 2024, this is a very recent study providing novel insights into neuropeptide Y regulation that have not been previously demonstrated in humans.

The bigger picture

This study advances our understanding of the neuroscience behind neuropeptide release in humans. While the role of NPY in cardiovascular regulation has been studied in animal models, human data on how sympathetic nerve firing patterns control peptide release has been essentially absent. The finding that NPY but not norepinephrine correlates with blood pressure changes challenges simple models of sympathetic cardiovascular control and highlights the importance of peptide co-transmitters in circulatory regulation.

Questions still open

Are NPY release patterns disrupted in conditions like essential hypertension or heart failure?
Could interventions that modify sympathetic firing patterns (like exercise or meditation) meaningfully alter NPY bioavailability?
Does the NPY-blood pressure relationship found here explain some of the cardiovascular effects of stress and anxiety?

Common questions

What is neuropeptide Y and why does it matter for cardiovascular health?

Neuropeptide Y (NPY) is one of the most abundant peptides in the brain and nervous system. It is released by sympathetic nerves alongside norepinephrine and plays important roles in constricting blood vessels, regulating blood pressure, controlling appetite, and modulating stress responses. Elevated NPY has been linked to hypertension and cardiovascular disease, making understanding its regulation clinically important.

What is microneurography and how does it work?

Microneurography is a technique where a tiny electrode is inserted through the skin into a peripheral nerve to record the electrical activity of individual nerve fibers in real time. In this study, it was used to record sympathetic nerve signals that control blood vessels, allowing researchers to see exactly how nerve firing patterns relate to the release of neuropeptide Y into the bloodstream.

Read the original research

Human sympathetic neuronal discharge and recruitment patterns regulate neuropeptide Y bioavailability.

American journal of physiology. Heart and circulatory physiology, 327(6), H1599-H1605

View on PubMed ↗Publisher’s paper ↗

Citation

Klassen, Stephen A; Limberg, Jacqueline K; Harvey, Ronée E; Wiggins, Chad C; Spafford, Julia E; Iannarelli, Nathaniel J; Senefeld, Jonathon W; Nicholson, Wayne T; Curry, Timothy B; Joyner, Michael J; Shoemaker, J Kevin; Baker, Sarah E. (2024). Human sympathetic neuronal discharge and recruitment patterns regulate neuropeptide Y bioavailability.. American journal of physiology. Heart and circulatory physiology, 327(6), H1599-H1605. https://doi.org/10.1152/ajpheart.00639.2024